Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: a systematic review and meta-analysis. | 2024 | Current Problems in Cardiology |
Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis. | 2024 | Journal of Orthopaedics and Traumatology |
Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis. | 2023 | Frontiers in Pharmacology |
Meta-analysis of outcomes following intravenous thrombolysis in patients with ischemic stroke on direct oral anticoagulants. | 2023 | BMC Neurology |
Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis. | 2023 | International Journal of Cardiology |
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis. | 2023 | Thrombosis Research |
Apixaban for the treatment of cerebral venous sinus thrombosis: a single-centre experience and systematic review of the literature. | 2023 | CNS Drugs |
An evidence-based approach to anticoagulation therapy comparing direct oral anticoagulants and vitamin k antagonists in patients with atrial fibrillation and bioprosthetic valves: a systematic review, meta-analysis, and network meta-analysis. | 2023 | The American Journal of Cardiology |
Efficacy and safety of apixaban versus dalteparin as a treatment for cancer-associated venous thromboembolism: a systematic review and meta-analysis. | 2023 | Medicina (Kaunas) |
Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: Systematic review. | 2023 | Journal of Formosan Association |
Efficacy and safety of direct oral anticoagulants for stroke prevention in older patients with atrial fibrillation: a network meta-analysis of randomized controlled trials. | 2023 | Journal of the American Heart Association |
Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: a systematic review and meta-analysis of observational studies. | 2023 | Journal of Thrombosis and Thrombolysis |
Meta-analysis comparing apixaban versus rivaroxaban for management of patients with nonvalvular atrial fibrillation. | 2022 | The American Journal of Cardiology |
Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. | 2022 | Future Cardiology |
Editor’s Choice – severe bleeding risks of direct oral anticoagulants in the prevention and treatment of venous thromboembolism: a network meta-analysis of randomised controlled trials. | 2022 | European Journal of Vascular & Endovascular Surgery |
Direct oral anticoagulants compared with dalteparin for treatment of cancer-associated thrombosis: a living, interactive systematic review and network meta-analysis. | 2022 | Mayo Clinic Proceedings |
Fracture risks in patients with atrial fibrillation treated with different oral anticoagulants: A meta-analysis and systematic review. | 2022 | Age and Aging |
Antithrombotic therapy with or without aspirin after percutaneous coronary intervention or acute coronary syndrome in patients taking oral anticoagulation: a meta-analysis and network analysis of randomized controlled trials. | 2022 | Cardiovascular Revascularization Medicine |
Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: A systematic review, pairwise and network meta-analysis. | 2022 | BMJ Open |
New oral anticoagulants for venous thromboembolism prophylaxis in total hip and knee arthroplasty: a systematic review and network meta-analysis. | 2022 | Frontiers in Pharmacology |
Direct oral anticoagulants for cancer-associated venous thromboembolisms: A systematic review and network meta-analysis. | 2022 | Internal Medicine Journal |
Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: A systematic review and network meta-analysis of randomized controlled trials. | 2022 | Annals of Medicine |
Risk of intracranial hemorrhage with direct oral anticoagulants: A systematic review and meta‑analysis of randomized controlled trials. | 2022 | Journal of Neurology |
Comparative risks of fracture among direct oral anticoagulants and warfarin: A systematic review and network meta-analysis. | 2022 | Frontiers in Cardiovascular Medicine |
Twice- or once-daily dosing of direct oral anticoagulants, a systematic review and meta-analysis. | 2021 | Thrombosis Research |
Safety and efficacy of apixaban, rivaroxaban, and warfarin in end-stage renal disease with atrial fibrillation: A systematic review and meta-analysis. | 2021 | Cardiovascular Revascularization Medicine |
Association of direct oral anticoagulants vs. vitamin K antagonists with fractures in atrial fibrillation patients: A systematic review and meta-analysis. | 2021 | Frontiers in Cardiovascular Medicine |
Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis. | 2021 | Journal of Clinical Pharmacy and Therapeutics |
Oral anticoagulant agents in patients with atrial fibrillation and CKD: A systematic review and pairwise network meta-analysis. | 2021 | American Journal of Kidney Diseases |
Severe bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention and treatment in patients with atrial fibrillation: A systematic review and network meta-analysis. | 2021 | Cardiovascular Drugs and Therapy |
Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and network meta-analysis. | 2021 | Current Medical Research and Opinion |
A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus. | 2021 | Acta Cardiologica |
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: A meta-analysis and systematic review. | 2021 | Cardiovascular Drugs and Therapy |
Bleeding outcomes after dental Extraction in patients under direct-acting oral anticoagulants vs. vitamin K antagonists: A systematic review and meta-analysis. | 2021 | Frontiers in Pharmacology |
Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: A systematic review. | 2021 | Age and Ageing |
Effectiveness of direct oral anticoagulants in obese adults with atrial fibrillation: A systematic review of systematic reviews and meta-analysis. | 2021 | Frontiers in Cardiovascular Medicine |
Efficacy and safety of non-vitamin K anticoagulants for atrial fibrillation in relation to different renal function levels: A network meta-analysis. | 2020 | Cardiovascular Therapeutics |
Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. | 2020 | Circulation: Cardiovascular Quality and Outcomes |
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: A systematic review and meta-analysis. | 2020 | Frontiers in Pharmacology |
Apixaban for stroke prevention in atrial fibrillation: why are event rates higher in clinical practice than in randomized trials?—A systematic review. | 2020 | Stroke, Systemic or Venous Thromboembolism |
Efficacy and safety of direct oral anticoagulants in elderly patients with atrial fibrillation: a network meta-analysis. | 2020 | Frontiers in Medicine |
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: a network meta-analysis. | 2020 | Medicine |
Direct oral anticoagulant use in chronic kidney disease and dialysis patients with venous thromboembolism: a systematic review of thrombosis and bleeding outcomes. | 2020 | Annals of Pharmacotherapy |
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. | 2019 | Nephrology Dialysis Transplantation |
A systematic review of network meta-analyses and real-world evidence comparing apixaban and rivaroxaban in nonvalvular atrial fibrillation. | 2019 | Clinical and Applied Thrombosis/Hemostasis |
Elderly bleeding risk of direct oral anticoagulants in nonvalvular atrial fibrillation: A systematic review and meta‑analysis of cohort studies. | 2019 | Drugs in R&D |
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and high thromboembolic risk. a systematic review. | 2019 | Frontiers in Pharmacology |
Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis. | 2019 | Scandinavian Cardiovascular Journal |
Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis. | 2019 | BMC Cardiovascular Disorders |
Indirect comparison of novel oral anticoagulants among Asians with non-valvular atrial fibrillation in the real-world setting: A network meta-analysis. | 2019 | BMC Cardiovascular Disorders |
Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis. | 2019 | Cochrane Database of Systematic Reviews |